|
Boster Bio
rabbit anti mouse bdnf ![]() Rabbit Anti Mouse Bdnf, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/Anti-BDNF+Rabbit+Monoclonal+Antibody/pmc04345655-127-24-28 Average 93 stars, based on 1 article reviews
rabbit anti mouse bdnf - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Genentech inc
rabbit anti-bdnf or anti-nt-3 antiserum ![]() Rabbit Anti Bdnf Or Anti Nt 3 Antiserum, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf+or+anti+nt+3+antiserum/10__1523_slash_jneurosci__21___07___02256__2001-89-3-5 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf or anti-nt-3 antiserum - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Amgen
rabbit anti-bdnf antibody ![]() Rabbit Anti Bdnf Antibody, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf/pmc06673161-67-8-13 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Institute for Clinical Pharmacodynamics
rabbit anti-bdnf 17h ![]() Rabbit Anti Bdnf 17h, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf+17h/pmc03990111-48-18-28 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf 17h - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Merck KGaA
rabbit anti-bdnf polyclonal antibody ab1779 ![]() Rabbit Anti Bdnf Polyclonal Antibody Ab1779, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf+polyclonal+antibody+ab1779/pmc07387769-102-11-17 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf polyclonal antibody ab1779 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Merck & Co
rabbit anti-bdnf ![]() Rabbit Anti Bdnf, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/sab2108004/pm37106468-84-6-10 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
GeneTex
rabbit anti-bdnf ![]() Rabbit Anti Bdnf, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf/pmc07256446-261-14-17 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Becton Dickinson
rabbit anti-bdnf ![]() Rabbit Anti Bdnf, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf/pmc05617778-151-61-63 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
FineTest Biotech Inc
polyclonal rabbit anti-bdnf antibody ![]() Polyclonal Rabbit Anti Bdnf Antibody, supplied by FineTest Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/polyclonal+rabbit+anti+bdnf+antibody/pmc05681553-273-12-16 Average 90 stars, based on 1 article reviews
polyclonal rabbit anti-bdnf antibody - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Signalway Antibody
rabbit anti-bdnf ![]() Rabbit Anti Bdnf, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf/pm33524786-140-26-29 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Wanleibio
rabbit anti-bdnf antibodies ![]() Rabbit Anti Bdnf Antibodies, supplied by Wanleibio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/rabbit+anti+bdnf+antibodies/pmc09750830-69-33-37 Average 90 stars, based on 1 article reviews
rabbit anti-bdnf antibodies - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Bioss
bdnf polyclonal antibody ![]() Bdnf Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rabbit+anti-bdnf/BDNF+Polyclonal+Antibody/custom%40bs-4989r%4028848078 Average 94 stars, based on 1 article reviews
bdnf polyclonal antibody - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Neural Regeneration Research
Article Title: Transplantation of human umbilical cord blood mesenchymal stem cells to treat a rat model of traumatic brain injury
doi: 10.3969/j.issn.1673-5374.2012.10.004
Figure Lengend Snippet: Neurotrophic factor expression in surrounding injured brain tissues following human umbilical cord blood mesenchymal stem cell transplantation. (A–C) Nerve growth factor (NGF) protein expression (immunohistochemistry, × 200); (D–F) brain-derived neurotrophic factor (BDNF) protein expression (immunohistochemistry, × 200); (G–I) BDNF mRNA expression ( in situ hybridization, × 400). (A, D, G) Results (absorbance) are expressed as mean ± SD from six rats in each group at each time point. a P < 0.05, vs . model group ( t -test was used to specify differences between two groups at the corresponding time points); (B, E, H) model group at 14 days after transplantation; (C, F, I) transplantation group at 14 days after transplantation. Arrows: NGF protein-, BDNF protein-, and BDNF mRNA-positive cells.
Article Snippet: Primary antibodies were incubated overnight at 4°C in wet box with the following dilutions: rat anti-human BrdU monoclonal antibody (1:150; Beijing Boaosen Biotechnology, China),
Techniques: Expressing, Transplantation Assay, Immunohistochemistry, Derivative Assay, In Situ Hybridization
Journal: The Journal of Neuroscience
Article Title: Transient Growth Factor Delivery Sustains Regenerated Axons after Spinal Cord Injury
doi: 10.1523/JNEUROSCI.1903-07.2007
Figure Lengend Snippet: Plasmid map of the tetracycline-regulatable retroviral expression vector pLN–tet-on and timeline of in vivo experiments. A, Expression of the reversed tetracycline transactivator (rtTA2s–M2) is driven by the 5′ long terminal repeat (5′LTR), and expression of the neomycin resistance gene (neo) is driven by an internal SV40 promoter (SV40). Note that the tet-responsive minimal cytomegalovirus promoter (CMV*−1) is oriented in the opposite orientation to the 5′LTR. cDNAs for BDNF and GFP, respectively, are inserted into the multiple cloning site. Two polyadenylation signals (polyA) are present, one located in the 3′LTR and a bovine growth hormone polyA signal behind the multiple cloning site for the inducible transcript. B, Survival and treatment of animals for histological and ELISA analysis. Duration of treatment with doxycycline in the drinking water is indicated by plus symbols (Dox++++), and survival without doxycycline treatment is indicated by the dashed line (No Dox—-). Note that several groups were first treated with doxycycline followed by doxycycline removal (++++ followed by —-). The number of animals used for histological analysis are indicated at each time point for each treatment group, and numbers in parentheses indicate animal numbers used for BDNF ELISAs.
Article Snippet: BDNF ELISA Ninety-six-well plates were coated with a
Techniques: Plasmid Preparation, Retroviral, Expressing, In Vivo, Cloning, Enzyme-linked Immunosorbent Assay
Journal: The Journal of Neuroscience
Article Title: Transient Growth Factor Delivery Sustains Regenerated Axons after Spinal Cord Injury
doi: 10.1523/JNEUROSCI.1903-07.2007
Figure Lengend Snippet: Dose dependence and kinetics of BDNF production in primary Fischer 344 rat fibroblasts transfected with tet-on–BDNF. A, With increasing concentrations of doxycycline in the cell culture medium, BDNF expression is increased. B, Kinetics of BDNF expression. tet-on–BDNF transfected cells were cultivated for 3 d with doxycycline (red and black lines) or without doxycycline (blue and green circles). Supernatants were collected beginning at time 0. One group (red line) was changed from doxycycline-containing to doxycycline-free medium, and one group (blue line) was changed from doxycycline-free to doxycycline-containing medium. BDNF levels were measured by ELISA. Cells that were constantly cultivated in doxycycline-free medium (green line) showed very little BDNF expression. Cells that were constantly treated with 1 μg/ml doxycycline (black line) showed continued BDNF expression. Cells that were first in doxycycline-free medium and were then changed to doxycycline-containing culture medium at time 0 (blue line) turned on gene expression within 12 h. This was evidenced by the 24 h supernatant (collected between the 12 and 24 h medium change), which contained high levels of BDNF. Cells that were first cultivated in doxycycline-containing medium and changed to doxycycline-free medium at time 0 (red line) nearly completely shut down gene expression after 24 h. Error bars in A and B are not always visible because of their small size.
Article Snippet: BDNF ELISA Ninety-six-well plates were coated with a
Techniques: Transfection, Cell Culture, Expressing, Enzyme-linked Immunosorbent Assay, Gene Expression
Journal: The Journal of Neuroscience
Article Title: Transient Growth Factor Delivery Sustains Regenerated Axons after Spinal Cord Injury
doi: 10.1523/JNEUROSCI.1903-07.2007
Figure Lengend Snippet: Regulated expression of GFP and BDNF in vivo. A, B, GFP fluorescence in grafts of genetically modified primary fibroblasts in the injured spinal cord 2 weeks after grafting. A, Animals that were treated with doxycycline (+Dox) show GFP fluorescence in the graft, whereas no GFP fluorescence can be found in animals that received GFP grafts in the absence of doxycycline administration (−Dox) (B). Host/graft (g) interface is indicated by dashed lines. C, D, Immunolabeling for GFP shows expression in grafts of animals that were treated with doxycycline for 3 months (C), whereas very weak GFP expression can be found in animals that received GFP grafts in the absence of doxycycline administration (−Dox) for 3 months (D). E, Regulated expression of BDNF in primary fibroblasts grafted to the injured spinal cord. Two weeks after grafting, GFP- and BDNF-expressing grafts were dissected from animals that were either untreated (−Dox) or treated with doxycycline in the drinking water (+Dox) to turn gene expression on. BDNF levels were determined by ELISA. tet-on–BDNF transfected fibroblast grafts from animals that were treated with doxycycline (BDNF + Dox) show significantly higher BDNF levels than untreated animals (BDNF − Dox) and animals with control grafts (***p < 0.001). BDNF levels in untreated animals with tet-on–BDNF transfected fibroblasts grafts are not significantly different from treated (p = 0.76) or untreated (p = 0.85) GFP transfected control animals. Scale bar: A, B, 283 μm; C, D, 138 μm.
Article Snippet: BDNF ELISA Ninety-six-well plates were coated with a
Techniques: Expressing, In Vivo, Fluorescence, Genetically Modified, Immunolabeling, Gene Expression, Enzyme-linked Immunosorbent Assay, Transfection, Control
Journal: Frontiers in Cellular Neuroscience
Article Title: High abundance of BDNF within glutamatergic presynapses of cultured hippocampal neurons
doi: 10.3389/fncel.2014.00107
Figure Lengend Snippet: Two anti-BDNF antibodies enable specific and dense indirect immunolabeling of endogenous BDNF in hippocampal neurons in vitro . (A) Antibody verification with recombinant BDNF. HeLa cells stably expressing lentivirally-delivered BDNF IRES GFP were labeled with different anti (α)-BDNF antibodies from different species (r, rabbit; m, mouse; s, sheep). Antibody details are given in the Material and Method section. As transduction control, GFP was expressed bicistronically under an IRES2 sequence and postlabeled with chicken anti-GFP. BDNF was accumulated in the early secretory trafficking pathway after microtubule disruption with nocodazole, causing a perinuclear Golgi-like staining pattern. (B) Immunoblot of rαBDNF (17 h). Serial dilutions of recombinant BDNF (250–31 pg per lane) served as control (left panel). Hippocampal BDNF harvested at postnatal day 5 was absent in bdnf −/− mice, while heterozygous and wildtype controls show mature BDNF at a M r of 13 kDa. HRP-conjugated anti-Cytochrome C (Cyt C) served as loading control (left panel). In adult mice, rαBDNF (17 h) revealed mature BDNF at high concentration in the hippocampus (left and right lane), while only low amounts were detected in cerebellar protein lysates (middle lane). (right panel). Immunoblots revealed high specificity of the antibody 17 h. (C) Endogenous BDNF in hippocampal neurons at day in vitro (DIV) 35. In somatic regions, BDNF was not concentrated in perinuclear Golgi cisternae, but rather in somatic vesicles. Golgi cisternae were labeled with luminal GFP, a marker for the anterograde, secretory pathway. Luminal GFP and endogenous BDNF co-labeled anterograde trafficking structures (arrow heads) in neurites of hippocampal neurons. Endogenous BDNF was double-labeled by two different anti-BDNF antibodies (rabbit anti-BDNF 17h and mouse anti-BDNF mab9). (D) Somatic anti-BDNF labels were lost when the bdnf gene was removed from single cells. Hippocampal neurons from bdnf fl/fl mice were transduced with a low titer of a lentivirus expressing tdTomato IRES Cre. Neurons (DIV 20) were labeled with anti-BDNF (mab9). Tomato+ cells (upper neuron, red, yellow arrow) lacked a typical vesicular somatic BDNF label, while untransduced, Tomato-Cre-deficient neurons (lower neuron, cyan arrow) exhibited a strong somatic BDNF label. In the composite image Tomato (red) and mouse anti-BDNF (mab9) (green) labels are shown together with an anti-neurofilament (Nfh) label (white) and a nuclear DAPI stain (blue). Bar: 25 μm.
Article Snippet: Blocking and antibody incubation were performed in 10% goat serum, 5% milk powder (Biorad) for 3–4 h. For
Techniques: Immunolabeling, In Vitro, Recombinant, Stable Transfection, Expressing, Labeling, Transduction, Control, Sequencing, Disruption, Staining, Western Blot, Concentration Assay, Marker
Journal: International Journal of Neuropsychopharmacology
Article Title: Sustained Ultrastructural Changes in Rat Hippocampal Formation After Repeated Electroconvulsive Seizures
doi: 10.1093/ijnp/pyaa021
Figure Lengend Snippet: Brain-derived neurotrophic factor (BDNF) expression levels were measured by immunohistochemistry in hippocampus. (A) BDNF expression in the subregions of hippocampus. (B–D) Immunohistochemistry examined BDNF expression levels in each group. Mean optical density (MOD) was calculated with the following formula: OD = log10(max pixel intensity/mean pixel intensity), where max pixel intensity = 255. A single ECS treatment significantly increased the MOD of BDNF expression in both FSL and FRL rat strains in CA1 of hippocampus in contrast to DG and CA2/3 of hippocampus. No difference between the FRL sham and FSL sham rats was observed. Three months after 10xECS, no changes of BDNF expression levels in hippocampal subregions between the FRL and FSL rats were observed.
Article Snippet: Tissue sections were incubated at 4°C overnight in a solution containing
Techniques: Derivative Assay, Expressing, Immunohistochemistry
Journal: International Journal of Neuropsychopharmacology
Article Title: Sustained Ultrastructural Changes in Rat Hippocampal Formation After Repeated Electroconvulsive Seizures
doi: 10.1093/ijnp/pyaa021
Figure Lengend Snippet: Results of All Groups in FSL Rats
Article Snippet: Tissue sections were incubated at 4°C overnight in a solution containing
Techniques:
Journal: International Journal of Neuropsychopharmacology
Article Title: Sustained Ultrastructural Changes in Rat Hippocampal Formation After Repeated Electroconvulsive Seizures
doi: 10.1093/ijnp/pyaa021
Figure Lengend Snippet: Results of All Groups in FRL Rats
Article Snippet: Tissue sections were incubated at 4°C overnight in a solution containing
Techniques:
Journal: Neurochemistry international
Article Title: DL-3-n-butylphthalide Induced Neuroprotection, Regenerative Repair, Functional Recovery and Psychological Benefits following Traumatic Brain Injury in Mice
doi: 10.1016/j.neuint.2017.03.017
Figure Lengend Snippet: TBI mice received acute as well as daily TBI intranasal treatments until sacrifice. Expressions of regenerative factors were measured using Western blot 21 days after TBI. A. The protein levels of BDNF, VEGF, GDNF, eNOS, CXCR4, and MMP-9. B. Quantified data from A. NBP treatments significantly enhanced the expression of BDNF, VEGF, eNOS, and MMP-9 compared to the control group. There was no significant change in GDNF and CXCR4 expressions among groups. * P<0.05 versus sham group; # P<0.05 versus TBI-saline control group by one-way ANOVA followed by Bonferroni correction; n=5 per group.
Article Snippet: The primary antibodies used and the dilutions for each were rabbit anti-cleaved caspase-3 antibody (Cell Signaling, Danvers, MA) at 1:400, rabbit anti-caspase-9 antibody (Cell Signaling) at 1: 1,000, rabbit anti-cytochrome c antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at 1:200 or rabbit anti-AIF antibody (Cell Signaling) at 1:500, rabbit anti-TNF-α (Cell Signaling) at 1:1000, rabbit anti-IL-1β (Cell Signaling) at 1:1000,
Techniques: Western Blot, Expressing
Journal: Clinical and Experimental Immunology
Article Title: The effects of maternal anti-alpha-enolase antibody expression on the brain development in offspring
doi: 10.1093/cei/uxac086
Figure Lengend Snippet: quantitative examination of glial cells in hippocampal and cortical tissues and assessment of cytokine and BDNF levels in the brain tissue of the pups from H-ENO1Ab dams. All the pups were obtained as depicted in . The expression levels of Iba-1 (A) and GFAP (B) in the hippocampal and cortical tissues from the pups of H-ENO1Ab dams and those of the control group on P10 and P40 ( n = 4/group, respectively) were quantitatively assessed by western blot. * P < 0.05 vs. the pups of the control group at the same age. (C) The average levels of cytokines in the supernatants of brain tissue homogenates from the pups of H-ENO1Ab dams and those of the control group on P10 were detected by microarray ( n = 4/group). NS vs. the pups of the control group. (D) The levels of BDNF in the brain tissues of the pups from H-ENO1Ab dams and those of the control group on P10 ( n = 4/group) were detected by western blot. * P < 0.05 vs. the pups of the control group on P10.
Article Snippet: The membranes were incubated at 4°C overnight with the following primary antibodies: rabbit anti-ENO1 antibodies (1:400, BIOSS), rabbit anti-Iba-1 antibodies (1:1000, Abcam), mouse anti-GFAP antibodies (1:1000, CST), rabbit anti-cleaved caspase-3 antibodies (1:1000, CST),
Techniques: Expressing, Control, Western Blot, Microarray